Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on June 23, 2025
Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
·
June 23, 2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the debut of …
ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study
GlobeNewswire
·
June 23, 2025
16.0 months median progression free survival (mPFS) with firmonertinib 240 mg by blinded independent central review (BICR) in first-line patients Robust central nervous system (CNS) activity; 41% (7/17) confirmed complete response (CR) and 53% confirmed …
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
June 23, 2025
WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor …
OTC Markets Group Welcomes Torex Gold Resources Inc. to OTCQX
GlobeNewswire
·
June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Torex Gold Resources Inc. (TSX: TXG; OTCQX: TORXF), an intermediate gold …
Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress
GlobeNewswire
·
June 23, 2025
REHOVOT, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …
Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
GlobeNewswire
·
June 23, 2025
Interactions with FDA over the past year have provided clear expectations for the path to submission of the nomlabofusp BLA Written FDA recommendations for safety database include a total of at least 30 participants with continuous exposure for 6 months …
Baylin Technologies to Present at the Small Cap Growth Virtual Investor Conference June 26th
GlobeNewswire
·
June 23, 2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Baylin Technologies Inc. (“Baylin” or the “Company”), based in Toronto, Ontario, Canada today announced that Chief Executive Officer Leighton Carroll, will present live at the Small Cap Growth Virtual Investor …
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
GlobeNewswire
·
June 23, 2025
The study met its primary and all secondary efficacy endpoints for all dose groups Single doses of 450mg, 300mg and 150mg of CD388 conferred 76%, 61% and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo CD388 was …
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)
GlobeNewswire
·
June 23, 2025
In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with complete preservation of lean mass, outperforming the group given semaglutide alone Icovamenib …
Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
GlobeNewswire
·
June 23, 2025
- Potential Best-In-Class Bispecific Antibody ATI-052 Targets Both Thymic Stromal Lymphopoietin (TSLP) and Interleukin-4 Receptor (IL-4R) - WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage …
TransUnion Appoints Alicia Zuiker Chief Human Resources Officer
GlobeNewswire
·
June 23, 2025
CHICAGO, June 23, 2025 (GLOBE NEWSWIRE) -- Alicia Zuiker has joined TransUnion (NYSE: TRU) as Executive Vice President, Chief Human Resources Officer (CHRO), effective June 23, 2025. Zuiker is an accomplished CHRO with deep experience leading global talent …
BYDFi MoonX Launches Global KOL Recruitment to Accelerate the On-Chain Trading Ecosystems
GlobeNewswire
·
June 23, 2025
VICTORIA, Seychelles, June 23, 2025 (GLOBE NEWSWIRE) -- MoonX, the on-chain MemeCoin trading tool developed by leading crypto exchange BYDFi, today officially launched its Global KOL Recruitment Program. This initiative invites content creators, community …
Portfolio Manager and Noted Macro and Market Analyst Bob Elliott Launches Substack Newsletter
GlobeNewswire
·
June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bob Elliott, former member of the Investment Committee at Bridgewater Associates and the CEO/CIO of alternative investment firm Unlimited, today announced the launch of Nonconsensus, a new economic and investing …
Given Almost $75 Million in Executed Preferred Stock Purchase Agreements, Hyperscale Data Does Not Currently Intend to Raise Additional Equity
GlobeNewswire
·
June 23, 2025
LAS VEGAS, June 23, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced that it does not currently intend to pursue additional equity offerings, given …
FLNG Gimi reaches Commercial Operations Date and Golar progresses FLNG growth
GlobeNewswire
·
June 23, 2025
Golar LNG Limited (“Golar”) is pleased to announce that FLNG Gimi has reached the Commercial Operations Date (“COD”) for its 20-year Lease and Operate Agreement for the Greater Tortue Ahmeyim (“GTA”) project offshore Mauritania and Senegal. The COD …
Global Net Lease Successfully Closes Third and Final Phase of Multi-Tenant Portfolio Sale
GlobeNewswire
·
June 23, 2025
— Sale of 12 Properties Generates Approximately $313 Million in Gross Proceeds — Portfolio Sale Completed; Accelerates Deleveraging Plan and Transforms GNL to Single-Tenant Net Lease REIT NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Global Net Lease, Inc. ( …
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire
·
June 23, 2025
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global …
Caledonia Mining Corporation Plc: High Grade Drill Results at Blanket Mine
GlobeNewswire
·
June 23, 2025
ST HELIER, Jersey, June 23, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or “the Company") is pleased to report further encouraging high grade results from the ongoing resource expansion drill programme at Caledonia’s 64% owned …
Polemos Launches $PLMS Token On MEXC and Uniswap, Advancing Web3 Gaming Infrastructure
Chainwire
·
June 23, 2025
Singapore, Singapore, June 23rd, 2025, Chainwire Polemos, a Web3 gaming infrastructure platform, started the official Token Generation Event (TGE) for the $PLMS utility token. The TGE began at 5:00 AM UTC on June 23rd, 2025, marking a step in the platform' …
SBC Medical Participated in 4 Investor Conferences in May and June 2025
GlobeNewswire
·
June 23, 2025
IRVINE, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, recently participated in several prominent investor conferences …